SIMILAR PATTERNS OF AMINO ACIDS FOR 4I00_A_ZMRA509_1
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ct9 | ASPARAGINESYNTHETASE B (Escherichiacoli) |
PF00733(Asn_synthase)PF13537(GATase_7) | 5 | ARG A 309ARG A 498GLU A 499ALA A 511GLU A 502 | None | 1.32A | 4i00A-1ct9A:undetectable | 4i00A-1ct9A:20.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ecx | AMINOTRANSFERASE (Thermotogamaritima) |
PF00266(Aminotran_5) | 5 | ARG A 249GLU A 252ALA A 261GLU A 256ARG A 16 | None | 1.47A | 4i00A-1ecxA:undetectable | 4i00A-1ecxA:22.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ms8 | TRANS-SIALIDASE (Trypanosomacruzi) |
PF13385(Laminin_G_3)PF13859(BNR_3) | 6 | ARG A 35ASP A 59GLU A 230ARG A 245ARG A 314TYR A 342 | DAN A 700 (-3.0A)DAN A 700 (-2.7A)DAN A 700 (-3.3A)DAN A 700 (-2.8A)DAN A 700 (-3.0A)DAN A 700 (-3.5A) | 0.92A | 4i00A-1ms8A:2.3 | 4i00A-1ms8A:21.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1mz5 | SIALIDASE (Trypanosomarangeli) |
PF13385(Laminin_G_3)PF13859(BNR_3) | 6 | ARG A 36ASP A 60GLU A 231ARG A 246ARG A 315TYR A 343 | None | 0.64A | 4i00A-1mz5A:11.3 | 4i00A-1mz5A:20.53 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1nmb | N9 NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 11 | ARG N 118GLU N 119ASP N 151ARG N 152ARG N 224GLU N 227ALA N 246GLU N 276GLU N 277ARG N 292TYR N 406 | None | 0.80A | 4i00A-1nmbN:62.7 | 4i00A-1nmbN:40.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1nmb | N9 NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 11 | ARG N 118GLU N 119ASP N 151ARG N 152ARG N 224GLU N 227ALA N 246GLU N 277ARG N 292ARG N 371TYR N 406 | None | 0.73A | 4i00A-1nmbN:62.7 | 4i00A-1nmbN:40.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1o94 | TRIMETHYLAMINEDEHYDROGENASE (Methylophilusmethylotrophus) |
PF00724(Oxidored_FMN)PF07992(Pyr_redox_2) | 5 | ARG A 354ASP A 683ALA A 703GLU A 372ARG A 375 | None | 1.09A | 4i00A-1o94A:undetectable | 4i00A-1o94A:18.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1v0z | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 12 | ARG A 124GLU A 125ASP A 157ARG A 158ARG A 231GLU A 234ALA A 253GLU A 283GLU A 284ARG A 299ARG A 378TYR A 412 | None | 0.55A | 4i00A-1v0zA:63.7 | 4i00A-1v0zA:50.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1vcj | NEURAMINIDASE (Influenza Bvirus) |
PF00064(Neur) | 11 | ARG A 116GLU A 117ASP A 149ARG A 150ARG A 223GLU A 226ALA A 245GLU A 276ARG A 292ARG A 374TYR A 409 | IBA A 1 (-3.3A)IBA A 1 (-3.9A)IBA A 1 (-3.6A)IBA A 1 (-3.9A)IBA A 1 ( 4.5A)IBA A 1 (-3.9A)IBA A 1 ( 3.9A)IBA A 1 (-3.9A)IBA A 1 (-3.5A)IBA A 1 (-3.2A)None | 0.65A | 4i00A-1vcjA:52.3 | 4i00A-1vcjA:34.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1vcj | NEURAMINIDASE (Influenza Bvirus) |
PF00064(Neur) | 8 | ARG A 116GLU A 117ASP A 149ARG A 150ARG A 223GLU A 275GLU A 276TYR A 409 | IBA A 1 (-3.3A)IBA A 1 (-3.9A)IBA A 1 (-3.6A)IBA A 1 (-3.9A)IBA A 1 ( 4.5A)IBA A 1 (-4.1A)IBA A 1 (-3.9A)None | 1.19A | 4i00A-1vcjA:52.3 | 4i00A-1vcjA:34.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1w8o | BACTERIAL SIALIDASE (Micromonosporaviridifaciens) |
PF00754(F5_F8_type_C)PF10633(NPCBM_assoc)PF13088(BNR_2) | 5 | ARG A 68GLU A 260ARG A 276ARG A 342TYR A 370 | CIT A1649 ( 2.6A)GOL A1651 (-3.6A)CIT A1649 ( 2.7A)CIT A1649 ( 2.9A)CIT A1649 (-4.5A) | 0.41A | 4i00A-1w8oA:4.2 | 4i00A-1w8oA:20.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1xog | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 11 | ARG A 119GLU A 120ASP A 152ARG A 153ARG A 226GLU A 229ALA A 248GLU A 279ARG A 294ARG A 372TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)ABW A1000 (-3.7A)ABW A1000 (-4.1A)NoneABW A1000 ( 4.0A)ABW A1000 ( 3.8A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 (-2.8A)ABW A1000 (-4.9A) | 0.49A | 4i00A-1xogA:62.9 | 4i00A-1xogA:47.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1xog | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 5 | ARG A 153ARG A 226GLU A 229ALA A 248GLU A 278 | ABW A1000 (-4.1A)NoneABW A1000 ( 4.0A)ABW A1000 ( 3.8A)ABW A1000 (-4.1A) | 0.93A | 4i00A-1xogA:62.9 | 4i00A-1xogA:47.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1y4j | SULFATASE MODIFYINGFACTOR 2 (Homo sapiens) |
PF03781(FGE-sulfatase) | 5 | ARG A 55GLU A 167ALA A 173GLU A 166ARG A 253 | None | 1.43A | 4i00A-1y4jA:undetectable | 4i00A-1y4jA:20.84 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2bf6 | EXO-ALPHA-SIALIDASE (Clostridiumperfringens) |
PF13088(BNR_2) | 6 | ARG A 266ASP A 291GLU A 539ARG A 555ARG A 615TYR A 655 | SIA A1692 (-2.7A)SIA A1692 (-2.8A)SIA A1692 ( 3.9A)SIA A1692 (-2.9A)SIA A1692 (-3.1A)SIA A1692 (-4.2A) | 0.49A | 4i00A-2bf6A:21.7 | 4i00A-2bf6A:21.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2f28 | SIALIDASE 2 (Homo sapiens) |
PF13088(BNR_2) | 5 | ARG A 21GLU A 218ARG A 237ARG A 304TYR A 334 | None | 0.39A | 4i00A-2f28A:21.2 | 4i00A-2f28A:20.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2gfg | BH2851 (Bacillushalodurans) |
PF01928(CYTH) | 5 | ARG A 184GLU A 149GLU A 151GLU A 6GLU A 8 | EDO A 503 (-4.2A)EDO A 503 (-3.0A)UNL A 500 ( 2.8A)UNL A 500 ( 3.9A)EDO A 503 ( 3.9A) | 1.48A | 4i00A-2gfgA:undetectable | 4i00A-2gfgA:17.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2htv | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 9 | ARG A 118ARG A 152ARG A 224GLU A 227GLU A 276GLU A 277ARG A 292ARG A 371TYR A 406 | None | 0.63A | 4i00A-2htvA:62.7 | 4i00A-2htvA:46.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2htv | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 7 | ARG A 118ASP A 151GLU A 227GLU A 277ARG A 292ARG A 371TYR A 406 | None | 0.58A | 4i00A-2htvA:62.7 | 4i00A-2htvA:46.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2htv | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 7 | GLU A 119ARG A 152ARG A 224GLU A 276GLU A 277ARG A 292TYR A 406 | None | 1.06A | 4i00A-2htvA:62.7 | 4i00A-2htvA:46.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2qni | UNCHARACTERIZEDPROTEIN ATU0299 (Agrobacteriumfabrum) |
PF00300(His_Phos_1) | 5 | ARG A 52GLU A 51ALA A 213GLU A 215GLU A 55 | None | 1.38A | 4i00A-2qniA:undetectable | 4i00A-2qniA:17.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2w20 | SIALIDASE A (Streptococcuspneumoniae) |
PF13088(BNR_2) | 6 | ARG A 347ASP A 372GLU A 647ARG A 663ARG A 721TYR A 752 | None | 0.60A | 4i00A-2w20A:5.9 | 4i00A-2w20A:21.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2xzi | EXTRACELLULARSIALIDASE/NEURAMINIDASE, PUTATIVE (Aspergillusfumigatus) |
PF13088(BNR_2) | 6 | ARG A 59ASP A 84GLU A 249ARG A 265ARG A 322TYR A 358 | KDM A 500 (-2.7A)KDM A 500 (-2.8A)KDM A 500 (-3.6A)KDM A 500 (-2.7A)KDM A 500 ( 3.0A)KDM A 500 (-4.5A) | 0.46A | 4i00A-2xziA:11.3 | 4i00A-2xziA:21.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ckz | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 11 | ARG A 118GLU A 119ASP A 151ARG A 152ARG A 224GLU A 227GLU A 276GLU A 277ARG A 292ARG A 371TYR A 406 | ZMR A 469 (-2.9A)ZMR A 469 (-3.5A)ZMR A 469 (-3.5A)ZMR A 469 (-3.9A)ZMR A 469 (-4.4A)ZMR A 469 (-3.5A)ZMR A 469 (-2.8A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A)ZMR A 469 (-2.9A)ZMR A 469 (-4.7A) | 0.30A | 4i00A-3ckzA:64.4 | 4i00A-3ckzA:46.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ln6 | GLUTATHIONEBIOSYNTHESISBIFUNCTIONAL PROTEINGSHAB (Streptococcusagalactiae) |
PF01071(GARS_A)PF04262(Glu_cys_ligase) | 5 | GLU A 626ARG A 614ALA A 590GLU A 631ARG A 655 | None | 1.28A | 4i00A-3ln6A:undetectable | 4i00A-3ln6A:18.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3sil | SIALIDASE (Salmonellaenterica) |
PF13859(BNR_3) | 6 | ARG A 37ASP A 62GLU A 231ARG A 246ARG A 309TYR A 342 | PO4 A 499 (-2.7A)GOL A 403 ( 3.4A)GOL A 402 (-3.3A)PO4 A 499 (-2.7A)PO4 A 499 (-3.0A)PO4 A 499 (-4.6A) | 0.76A | 4i00A-3silA:19.7 | 4i00A-3silA:23.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ti8 | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 12 | ARG A 118GLU A 119ASP A 151ARG A 152ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292ARG A 371TYR A 406 | LNV A 901 (-3.0A)LNV A 901 (-3.6A)LNV A 901 (-3.4A)LNV A 901 (-4.0A)LNV A 901 (-4.1A)LNV A 901 (-3.4A)LNV A 901 (-3.5A)LNV A 901 (-2.9A)LNV A 901 ( 3.8A)LNV A 901 (-2.8A)LNV A 901 (-2.9A)LNV A 901 (-4.8A) | 0.38A | 4i00A-3ti8A:65.2 | 4i00A-3ti8A:45.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3tia | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 12 | ARG A 118GLU A 119ASP A 151ARG A 152ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292ARG A 371TYR A 406 | LNV A 801 (-2.8A)LNV A 801 (-3.5A)LNV A 801 (-3.4A)LNV A 801 (-3.9A)LNV A 801 (-4.2A)LNV A 801 (-3.5A)LNV A 801 (-3.4A)LNV A 801 (-2.9A)LNV A 801 (-3.8A)LNV A 801 (-3.0A)LNV A 801 (-2.9A)LNV A 801 (-4.4A) | 0.41A | 4i00A-3tiaA:65.4 | 4i00A-3tiaA:45.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3zie | SEPF-LIKE PROTEIN (Archaeoglobusfulgidus) |
PF04472(SepF) | 5 | ARG A 55GLU A 52GLU A 56ARG A 40TYR A 38 | None | 1.12A | 4i00A-3zieA:undetectable | 4i00A-3zieA:12.91 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4b7j | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 8 | ARG A 118ASP A 151ARG A 152ARG A 225GLU A 228GLU A 277GLU A 278TYR A 402 | G39 A1470 (-3.1A)G39 A1470 (-3.7A)G39 A1470 (-3.9A)G39 A1470 (-4.4A)NoneG39 A1470 (-3.7A)G39 A1470 (-4.2A)G39 A1470 (-4.5A) | 0.59A | 4i00A-4b7jA:64.0 | 4i00A-4b7jA:40.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4b7j | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 10 | ARG A 118GLU A 119ASP A 151ARG A 152ARG A 225GLU A 228GLU A 278ARG A 293ARG A 368TYR A 402 | G39 A1470 (-3.1A)G39 A1470 (-3.5A)G39 A1470 (-3.7A)G39 A1470 (-3.9A)G39 A1470 (-4.4A)NoneG39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 (-3.0A)G39 A1470 (-4.5A) | 0.42A | 4i00A-4b7jA:64.0 | 4i00A-4b7jA:40.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4b7j | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 5 | ARG A 223GLU A 278ARG A 293ARG A 368TYR A 402 | G39 A1470 (-4.0A)G39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 (-3.0A)G39 A1470 (-4.5A) | 1.08A | 4i00A-4b7jA:64.0 | 4i00A-4b7jA:40.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4bbw | SIALIDASE(NEURAMINIDASE) (Bacteroidesthetaiotaomicron) |
PF13088(BNR_2)PF14873(BNR_assoc_N) | 5 | ARG A 204ASP A 229GLU A 399ARG A 415TYR A 510 | None | 0.83A | 4i00A-4bbwA:21.5 | 4i00A-4bbwA:21.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4bbw | SIALIDASE(NEURAMINIDASE) (Bacteroidesthetaiotaomicron) |
PF13088(BNR_2)PF14873(BNR_assoc_N) | 5 | ARG A 204GLU A 399ARG A 415ARG A 479TYR A 510 | None | 0.64A | 4i00A-4bbwA:21.5 | 4i00A-4bbwA:21.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4cpn | NEURAMINIDASE (Influenza Bvirus) |
PF00064(Neur) | 12 | ARG A 115GLU A 116ASP A 148ARG A 149ARG A 222GLU A 225ALA A 244GLU A 274GLU A 275ARG A 291ARG A 373TYR A 408 | ZMR A 700 (-2.9A)ZMR A 700 (-3.5A)ZMR A 700 (-3.3A)ZMR A 700 (-4.0A)ZMR A 700 (-3.8A)ZMR A 700 (-3.5A)ZMR A 700 (-3.6A)ZMR A 700 (-2.7A)ZMR A 700 (-3.4A)ZMR A 700 (-2.8A)ZMR A 700 (-3.0A)ZMR A 700 (-4.6A) | 0.43A | 4i00A-4cpnA:53.1 | 4i00A-4cpnA:30.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4fj6 | GLYCOSIDE HYDROLASEFAMILY 33, CANDIDATESIALIDASE (Parabacteroidesdistasonis) |
PF13859(BNR_3)PF14873(BNR_assoc_N) | 6 | ARG A 200ASP A 225GLU A 395ARG A 411ARG A 475TYR A 506 | PO4 A 607 ( 2.6A)PO4 A 607 ( 3.8A)PO4 A 607 ( 4.8A)PO4 A 607 (-2.7A)PO4 A 607 (-2.8A)PO4 A 607 (-4.6A) | 0.56A | 4i00A-4fj6A:21.4 | 4i00A-4fj6A:20.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4fzh | HEMAGGLUTININ-NEURAMINIDASE (Avianavulavirus 1) |
PF00423(HN) | 5 | ARG A 174GLU A 401ARG A 416ARG A 498TYR A 526 | None | 0.68A | 4i00A-4fzhA:12.3 | 4i00A-4fzhA:20.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4h53 | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 11 | ARG A 118GLU A 119ASP A 151ARG A 152ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292ARG A 371 | SLB A 512 (-2.7A)SLB A 512 (-3.5A)SLB A 512 (-3.5A)SLB A 512 (-3.8A)SLB A 512 (-4.2A)NoneSLB A 512 (-3.3A)SLB A 512 (-2.8A)SLB A 512 (-2.7A)SLB A 512 (-3.1A)SLB A 512 (-2.9A) | 0.45A | 4i00A-4h53A:65.5 | 4i00A-4h53A:53.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4h53 | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 5 | GLU A 227ARG A 152ALA A 246GLU A 276ARG A 292 | NoneSLB A 512 (-3.8A)SLB A 512 (-3.3A)SLB A 512 (-2.8A)SLB A 512 (-3.1A) | 1.49A | 4i00A-4h53A:65.5 | 4i00A-4h53A:53.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4hxt | DE NOVO PROTEINOR329 (syntheticconstruct) |
PF00514(Arm) | 5 | ARG A 108ARG A 66GLU A 101ALA A 27GLU A 63 | None | 1.37A | 4i00A-4hxtA:undetectable | 4i00A-4hxtA:18.81 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4hzz | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 11 | ARG A 118GLU A 119ASP A 151ARG A 152ARG A 224GLU A 227ALA A 246GLU A 277ARG A 292ARG A 371TYR A 406 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)G39 A 509 (-3.6A)G39 A 509 (-3.9A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-2.8A)G39 A 509 (-2.9A)G39 A 509 (-4.6A) | 0.45A | 4i00A-4hzzA:75.2 | 4i00A-4hzzA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4hzz | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 8 | GLU A 119ASP A 151ARG A 152ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277 | G39 A 509 (-3.3A)G39 A 509 (-3.6A)G39 A 509 (-3.9A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.1A)G39 A 509 ( 4.0A) | 0.72A | 4i00A-4hzzA:75.2 | 4i00A-4hzzA:100.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4jf7 | HEMAGGLUTININ-NEURAMINIDASE (Mammalianrubulavirus 5) |
no annotation | 5 | ARG D 163GLU D 390ARG D 405ARG D 495TYR D 523 | SO4 D 608 ( 4.1A)NoneSO4 D 608 (-2.6A)SO4 D 608 (-3.3A)None | 0.64A | 4i00A-4jf7D:8.9 | 4i00A-4jf7D:21.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4mju | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 9 | ARG A 118ARG A 152ARG A 224GLU A 227ALA A 246GLU A 277ARG A 292ARG A 371TYR A 406 | 27S A 501 (-3.0A)27S A 501 (-4.2A)27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.54A | 4i00A-4mjuA:62.9 | 4i00A-4mjuA:46.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4mju | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 7 | ARG A 118ARG A 152ARG A 224GLU A 227GLU A 276GLU A 277TYR A 406 | 27S A 501 (-3.0A)27S A 501 (-4.2A)27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-4.6A) | 0.68A | 4i00A-4mjuA:62.9 | 4i00A-4mjuA:46.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4mju | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 6 | ARG A 118ASP A 151ARG A 152GLU A 227ALA A 246TYR A 406 | 27S A 501 (-3.0A)27S A 501 (-3.2A)27S A 501 (-4.2A)27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 (-4.6A) | 0.91A | 4i00A-4mjuA:62.9 | 4i00A-4mjuA:46.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4mju | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 5 | ARG A 152GLU A 119ALA A 246ARG A 371TYR A 406 | 27S A 501 (-4.2A)27S A 501 (-3.4A)27S A 501 ( 3.8A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 1.30A | 4i00A-4mjuA:62.9 | 4i00A-4mjuA:46.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4mju | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 5 | ASP A 151ARG A 152GLU A 119ALA A 246TYR A 406 | 27S A 501 (-3.2A)27S A 501 (-4.2A)27S A 501 (-3.4A)27S A 501 ( 3.8A)27S A 501 (-4.6A) | 1.40A | 4i00A-4mjuA:62.9 | 4i00A-4mjuA:46.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4mju | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 7 | GLU A 119ARG A 152ARG A 224ALA A 246GLU A 277ARG A 292TYR A 406 | 27S A 501 (-3.4A)27S A 501 (-4.2A)27S A 501 (-4.3A)27S A 501 ( 3.8A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 1.11A | 4i00A-4mjuA:62.9 | 4i00A-4mjuA:46.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4q6k | BNR/ASP-BOX REPEATPROTEIN (Bacteroidescaccae) |
PF13088(BNR_2)PF14873(BNR_assoc_N) | 6 | ARG A 220ASP A 245GLU A 415ARG A 431ARG A 495TYR A 526 | EDO A 604 (-4.0A)EDO A 604 ( 4.3A)NoneNoneNoneNone | 0.47A | 4i00A-4q6kA:5.9 | 4i00A-4q6kA:18.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4qn3 | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 11 | ARG A 36GLU A 37ASP A 69ARG A 70ARG A 143GLU A 146ALA A 165GLU A 195GLU A 196ARG A 290TYR A 324 | None | 0.62A | 4i00A-4qn3A:63.7 | 4i00A-4qn3A:47.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4qn3 | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 11 | ARG A 36GLU A 37ASP A 69ARG A 70ARG A 143GLU A 146ALA A 165GLU A 196ARG A 211ARG A 290TYR A 324 | None | 0.39A | 4i00A-4qn3A:63.7 | 4i00A-4qn3A:47.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4sli | INTRAMOLECULARTRANS-SIALIDASE (Macrobdelladecora) |
PF02973(Sialidase)PF13088(BNR_2) | 5 | ALA A 592GLU A 595ARG A 611ARG A 673TYR A 713 | NoneCNP A 760 ( 4.5A)CNP A 760 (-3.0A)CNP A 760 (-3.0A)CNP A 760 (-4.0A) | 1.02A | 4i00A-4sliA:21.6 | 4i00A-4sliA:21.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4sli | INTRAMOLECULARTRANS-SIALIDASE (Macrobdelladecora) |
PF02973(Sialidase)PF13088(BNR_2) | 6 | ARG A 293ASP A 318GLU A 595ARG A 611ARG A 673TYR A 713 | CNP A 760 (-3.0A)CNP A 760 (-2.6A)CNP A 760 ( 4.5A)CNP A 760 (-3.0A)CNP A 760 (-3.0A)CNP A 760 (-4.0A) | 0.57A | 4i00A-4sliA:21.6 | 4i00A-4sliA:21.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4txk | PROTEIN-METHIONINESULFOXIDE OXIDASEMICAL1 (Mus musculus) |
PF00307(CH)PF01494(FAD_binding_3) | 5 | ARG A 230GLU A 373ALA A 473GLU A 437ARG A 371 | None | 1.14A | 4i00A-4txkA:undetectable | 4i00A-4txkA:18.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4x6k | ANHYDROSIALIDASE ([Ruminococcus]gnavus) |
PF13088(BNR_2) | 5 | ARG A 257ALA A 556ARG A 575ARG A 637TYR A 677 | 3XR A 802 (-3.0A)None3XR A 802 (-2.6A)3XR A 802 (-3.0A)3XR A 802 (-4.2A) | 0.99A | 4i00A-4x6kA:18.5 | 4i00A-4x6kA:21.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4x6k | ANHYDROSIALIDASE ([Ruminococcus]gnavus) |
PF13088(BNR_2) | 6 | ARG A 257ASP A 282GLU A 559ARG A 575ARG A 637TYR A 677 | 3XR A 802 (-3.0A)3XR A 802 (-2.5A)3XR A 802 ( 4.7A)3XR A 802 (-2.6A)3XR A 802 (-3.0A)3XR A 802 (-4.2A) | 0.60A | 4i00A-4x6kA:18.5 | 4i00A-4x6kA:21.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4xhb | SIALIDASE B (Streptococcuspneumoniae) |
PF02012(BNR)PF02973(Sialidase)PF13088(BNR_2) | 5 | ARG A 245ALA A 538ARG A 557ARG A 619TYR A 653 | NHE A 702 (-2.7A)NoneNHE A 702 (-2.8A)NHE A 702 (-2.9A)NHE A 702 (-4.8A) | 1.22A | 4i00A-4xhbA:19.2 | 4i00A-4xhbA:20.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4xhb | SIALIDASE B (Streptococcuspneumoniae) |
PF02012(BNR)PF02973(Sialidase)PF13088(BNR_2) | 6 | ARG A 245ASP A 270GLU A 541ARG A 557ARG A 619TYR A 653 | NHE A 702 (-2.7A)NHE A 702 (-3.2A)NoneNHE A 702 (-2.8A)NHE A 702 (-2.9A)NHE A 702 (-4.8A) | 0.61A | 4i00A-4xhbA:19.2 | 4i00A-4xhbA:20.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4yw5 | NEURAMINIDASE C (Streptococcuspneumoniae) |
PF02012(BNR)PF02973(Sialidase)PF13088(BNR_2) | 6 | ARG A 290ASP A 315GLU A 584ARG A 600ARG A 662TYR A 695 | G39 A 801 (-2.6A)G39 A 801 (-3.2A)G39 A 801 ( 4.7A)G39 A 801 (-2.9A)G39 A 801 (-2.9A)G39 A 801 (-4.4A) | 0.74A | 4i00A-4yw5A:20.6 | 4i00A-4yw5A:21.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5b2d | HN PROTEIN (Mumpsrubulavirus) |
PF00423(HN) | 5 | ARG A 180GLU A 407ARG A 422ARG A 512TYR A 540 | SLT A 606 (-2.6A)SLT A 606 (-3.8A)SLT A 606 (-3.0A)SLT A 606 (-2.8A)SLT A 606 (-4.7A) | 0.50A | 4i00A-5b2dA:21.9 | 4i00A-5b2dA:21.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5dot | CARBAMOYL-PHOSPHATESYNTHASE [AMMONIA],MITOCHONDRIAL (Homo sapiens) |
PF00117(GATase)PF00988(CPSase_sm_chain)PF02142(MGS)PF02786(CPSase_L_D2)PF02787(CPSase_L_D3) | 5 | ARG A 929ASP A 914ARG A 814GLU A1034ARG A1039 | NoneNoneEDO A1603 (-3.9A)EDO A1603 (-2.7A)EDO A1603 ( 3.8A) | 1.23A | 4i00A-5dotA:undetectable | 4i00A-5dotA:13.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6br6 | NEURAMINIDASE (Influenza Avirus) |
no annotation | 12 | ARG A 118GLU A 119ASP A 151ARG A 152ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292ARG A 371TYR A 406 | E3M A 511 (-3.0A)E3M A 511 (-3.6A)E3M A 511 (-2.9A)E3M A 511 (-3.8A)E3M A 511 (-3.8A)E3M A 511 ( 4.8A)E3M A 511 (-3.1A)E3M A 511 (-2.3A)E3M A 511 ( 3.6A)E3M A 511 (-2.9A)E3M A 511 (-2.9A)E3M A 511 (-4.5A) | 0.44A | 4i00A-6br6A:65.7 | 4i00A-6br6A:12.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6eks | SIALIDASE (Vibrio cholerae) |
no annotation | 6 | ARG A 250ASP A 276GLU A 645ARG A 661ARG A 738TYR A 766 | G39 A 908 (-2.8A)G39 A 908 (-3.3A)G39 A 908 (-4.0A)G39 A 908 (-2.8A)G39 A 908 (-3.0A)G39 A 908 (-4.6A) | 0.45A | 4i00A-6eksA:12.3 | 4i00A-6eksA:19.66 |